2020
DOI: 10.1186/s13104-020-05233-9
|View full text |Cite
|
Sign up to set email alerts
|

Survival rates of head and neck cancers in Ghana: a retrospective study at the Komfo Anokye Teaching Hospital

Abstract: Objective: Data was collected to evaluate the survival rates of head and neck (conjunctiva, oropharyngeal and nonoropharyngeal) squamous cell carcinomas in Ghana. Data description: We provided data on a retrospective review of 8 years (January 2004 to December 2009) survival rate of head and neck squamous cell carcinomas (HNSCCs) at the Komfo Anokye Teaching Hospital in Ghana. The data consist of patient demographic data and clinicopathological findings which includes tumour site, tumour stage and histological… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Recently, HNSCC therapy includes antibody treatment such as cetuximab against EGFR, pembrolizumab against programmed cell death protein 1, and nivolumab against programmed cell death protein ligand-1 [8][9][10]. Despite recent advances in the diagnosis and treatment of HNSCC, there has unsatisfied improvement in survival rates of HNSCC patients over the last few decades [11]. Therefore, it is important to explore new therapeutic targets or strategies for the treatment of HNSCC.…”
mentioning
confidence: 99%
“…Recently, HNSCC therapy includes antibody treatment such as cetuximab against EGFR, pembrolizumab against programmed cell death protein 1, and nivolumab against programmed cell death protein ligand-1 [8][9][10]. Despite recent advances in the diagnosis and treatment of HNSCC, there has unsatisfied improvement in survival rates of HNSCC patients over the last few decades [11]. Therefore, it is important to explore new therapeutic targets or strategies for the treatment of HNSCC.…”
mentioning
confidence: 99%